BD
Black Diamond Therapeutics, Inc.
BDTX · NASDAQ
$1.88 -1.57% (-$0.03)
1M -15.70%
Market Cap $108.3M
P/E Ratio -
Div. Yield -
ROE 38.80%
Bulios Fair Price
$2.52
34.0% upside
Current Price
$1.88
Undervalued Fair Value Overvalued
According to Bulios Fair Price, BDTX is currently undervalued relative to its market price. How does it work?
Bulios Fair Price is an estimate of a stock's fair value from the Bulios valuation model. It is an input for your own analysis, not investment advice. How does it work?
Analysis
An AI report on the business, its finances, valuation, sentiment, news and risks - written in a few minutes.
Piotroski F-Score Weak
1/9Valuation
100 /100
Cheap P/B 1.13x
P/E N/A
EV/EBITDA N/A
Growth
20 /100
Declining Book val. growth 1.01%
EPS growth N/A
Rev. growth N/A
Profitability
-
N/A Gross margin N/A
Net margin N/A
Op. margin N/A
Quality
0 /100
Poor ROIC 45.91%
ROE 38.80%
ROA 34.04%
Debt
100 /100
Low Debt/Equity 0.18x
Current ratio 7.28x
Int. coverage N/A
Stability
16 /100
Unstable Beta 3.31x
EPS volatility 58.87%
Profitable years 1
Bulios Scoring describes a company's quality and track record, not its future return. A high score is not a buy signal. Learn more
Ask StockBot about BDTX
Online
Sector
Healthcare
Industry
Biotechnology
CEO
Mark A. Velleca
Employees
21
Headquarters
Cambridge
Upcoming events
05 NOV
Earnings
Upcoming earnings report